Abstract

Transdermal drug delivery provides several advantages over conventional drug administration, such as the avoidance of first-pass metabolism and better patient compliance. In vitro research can abbreviate and facilitate the pharmaceutical development considerably compared to in vivo research as drug screening and clinical studies can be reduced. These advantages led to the development of corresponding skin models. Viable skin models are more useful than non-viable ones, due to the influence of skin metabolism on the results. While most in vitro studies concentrate on evaluating human-based models, the current study is designed for the investigation of both human and animal diseases. So far, there is little information available in the literature about viable animal skin cultures which are in fact intended for application in the veterinary and not the human field. Hence, the current study aims to fill the gap. For the in vitro viable skin model, specimens of human, porcine and canine skin were cultured over two weeks under serum-free conditions. To evaluate the influence of medium supplementation on skin viability, two different supplement mixtures were compared with basic medium. The skin specimens were maintained at a viability-level >50% until the end of the study. From the tested supplements, the addition of bovine pituitary extract and epidermal growth factor increased skin viability whereas hydrocortisone and insulin induced a decrease. This in vitro viable skin model may be a useful tool for the investigation of skin diseases, especially for the veterinary field.

Highlights

  • Transdermal drug delivery (TDD), compared to oral and parenteral drug administration, offers several advantages such as a decreased risk for toxicity and adverse effects, avoidance of first-pass metabolism and better patient compliance (Lee et al, 2018; Prausnitz, Mitragotri & Langer, 2004)

  • Percutaneous absorption and skin metabolism of pig ear skin was evaluated by Jacques et al (2010) While the sample processing and cultivation conditions were similar to the current study, the skin was sectioned to a defined thickness with a dermatome and only a short-term culture of 48 h was performed

  • These conditions are similar to the ones employed in the current study, the skin was only maintained until day 7 and four mm skin biopsies have been collected in contrast to skin culture over 14 days and 13 mm punches in this study

Read more

Summary

Introduction

Transdermal drug delivery (TDD), compared to oral and parenteral drug administration, offers several advantages such as a decreased risk for toxicity and adverse effects, avoidance of first-pass metabolism and better patient compliance (Lee et al, 2018; Prausnitz, Mitragotri & Langer, 2004). In order to facilitate and abbreviate the pharmaceutical development process, an increasing trend to the transfer from in vivo to in vitro research has been observed during the last few decades (Kim, Stein & O’Hare, 2004; Tsang & Bhatia, 2004). The social acceptance for animal testing has remarkably decreased (Bekoff, 2009; Kolar, 2006; PETA UK, 0000), resulting in corresponding changes in legislation. Establishment of an in vitro model of cultured viable human, porcine and canine skin and comparison of different media supplements.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call